Knights of Columbus Asset Advisors’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.74M Buy
290,345
+1,607
+0.6% +$15.3K 0.14% 164
2026
Q1
$2.64M Sell
288,738
-1,547
-0.5% -$13K 0.15% 154
2025
Q4
$2.16M Sell
290,285
-9,475
-3% -$68.1K 0.12% 180
2025
Q3
$2.01M Buy
299,760
+9,060
+3% +$62.9K 0.11% 193
2025
Q2
$1.92M Buy
+290,700
New +$2.06M 0.12% 189

Other funds holding BVS

Knights of Columbus Asset Advisors's BVS Position: Q2 2026 in Review

Knights of Columbus Asset Advisors increased its Bioventus (BVS) stake by 0.56% in Q2 2026, buying an estimated $15.3K and bringing the position to 290,345 shares worth $2.74M. The position accounts for 0.14% of the portfolio, ranked #164.

Knights of Columbus Asset Advisors first reported a position in BVS in Q2 2025 and has held it in 5 quarters since. 56 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Knights of Columbus Asset Advisors held 290,345 shares of Bioventus worth $2.74M as of Q2 2026.
  • Knights of Columbus Asset Advisors bought 1,607 Bioventus shares in Q2 2026, an estimated $15.3K.
  • Bioventus made up 0.14% of Knights of Columbus Asset Advisors's portfolio in Q2 2026, its #164 holding.
  • Knights of Columbus Asset Advisors first reported a position in Bioventus in Q2 2025 and has held it in 5 quarters since.
  • 56 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.